Two new dry powder inhalers will soon hit the market
Two new DRY POWDER inhalers will soon hit the market...Glaxo's Flovent Rotadisk and Serevent Diskus.
These have been developed as an alternative to aerosol MDIs...because of the upcoming ban on chlorofluorocarbon propellants.
Dry powder inhalers are also easier for some patients to use. They're breath-activated...patients DON'T have to coordinate their breathing with the actuation of the inhaler.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote